Skip to main content
Full access
Communications and Updates
Published Online: 1 October 2014

Neuroinflammation Versus Decreased Zif268 mRNA Expression as Causal Mediators of Decreased GAD67 mRNA Expression Within Dorsolateral Prefrontal Cortex in Schizophrenia

To the Editor: Kimoto et al. recently reported findings from an important study that quantified glutamic acid decarboxylase 67-kDa (GAD67) and Zif268 mRNA expression in postmortem dorsolateral prefrontal cortex specimens from 62 schizophrenia subjects and 62 paired nonpsychiatric controls (1). GAD67 and Zif268 mRNA expression levels were 14% and 32% lower on average among schizophrenia versus control subjects, though Zif268 mRNA expression levels were higher in 13 schizophrenia subjects compared with paired control subjects. In addition, GAD67 and Zif268 mRNA expression positively correlated in schizophrenia subjects (Pearson's r=0.29, p=0.027; N=58) but not controls. The authors interpreted these findings as supporting their hypothesis that decreased Zif268 mRNA expression constitutes a causal mediator of decreased GAD67 mRNA expression in schizophrenia.
Whereas the observed decreases in GAD67 and Zif268 mRNA expression are based on rigorous methods, are highly statistically significant, and were documented at different resolutions using quantitative polymerase chain reaction and in situ hybridization, some factors regarding the observed correlation between GAD67 and Zif268 mRNA expression merit consideration. First, the correlation coefficient (Pearson's r=0.29) indicates a borderline weak correlation (Pearson’s r versus correlation strength [c.]: 0.00–0.20=negligible, 0.20–0.29=weak, 0.30–0.39=moderate, 0.40–0.69=strong, 0.70–1.00=highly correlated). Undertaking sensitivity analyses might help decrease the risk of type I error. Such analyses might include nonparametric correlation tests (Spearman’s ρ), delimiting correlation tests to the schizophrenia subjects with lower Zif268 mRNA expression (N=49/62), reincluding outliers, and performing adjusted linear regressions. In addition, providing more detail on how included subjects were determined (e.g., consecutive/unselected versus convenience/selected, proportion of excluded subjects with reasons) would allow an informed assessment of selection bias risk.
The authors acknowledged that factors other than decreased Zif268 mRNA expression might also contribute to decreased cortical GAD67 mRNA expression in schizophrenia and discussed several alternative putative mechanisms. However, these alternatives did not include neuroinflammation. Neuropathological and neuroimaging studies have provided evidence implicating neuroinflammatory mechanisms in decreased cortical GAD67 mRNA expression in schizophrenia (2). For example, one neuropathological study documented lower cortical GAD67 mRNA expression among schizophrenia subjects with high versus low proinflammatory cytokine mRNA expression (3). The neuroinflammation model hypothesizes that prenatal insult induces microglial priming, particularly within white matter, resulting in neuroinflammation-mediated disruption of neuronal migration from periventricular germinal matrix to cortex. Thus, the neuroinflammation model maintains external validity not only with decreased cortical GAD67 mRNA expression findings but also with evidence of increased white matter neuronal density and with structural and functional white matter disconnectivity in schizophrenia, reproducible abnormalities central to neurodevelopmental and neurodegenerative hypotheses. Accordingly, neuroinflammatory mechanisms represent relevant context to the study findings.

References

1.
Kimoto S, Bazmi HH, Lewis DA: Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry (Epub ahead of print, May 30, 2014)
2.
Najjar S, Pearlman DM: Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res (Epub ahead of print, June 16, 2014)
3.
Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, Cairns M, Weickert CS: Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013; 18:206–214

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1117 - 1118
PubMed: 25272348

History

Accepted: July 2014
Published online: 1 October 2014
Published in print: October 2014

Authors

Details

Daniel M. Pearlman, M.P.H.
From the Department of Neurology, New York University School of Medicine, New York; and The Dartmouth Institute for Health Policy and Clinical Practice, Audrey and Theodor Geisel School of Medicine at Dartmouth, Hanover, N.H.
Souhel Najjar, M.D.
From the Department of Neurology, New York University School of Medicine, New York; and The Dartmouth Institute for Health Policy and Clinical Practice, Audrey and Theodor Geisel School of Medicine at Dartmouth, Hanover, N.H.

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share